Abstract
Cytomegalovirus (CMV) remains the most common cause of congenitally-acquired infection in the United States and is a leading infectious cause of sensorineural hearing loss, cognitive delay, and permanent neurologic sequelae. Although most cases of congenital CMV infection are asymptomatic, significant morbidity and mortality exist for symptomatic infants and may also occur in asymptomatic ones. Diagnosis remains relatively straightforward, but treatment options are limited and associated with some toxicity. Efforts at prevention via vaccination, screening, and improved epidemiology deserve high priority to limit the impact of this common infection.
Keywords: Congenital cytomegalovirus, infection, neonate, sensorineural hearing loss, deafness, congenital CMV, asymptomatic, microcephaly, congenital syphilis, chorioretinitis, EPIDEMIOLOGY, hepatosplenomegaly, primary CMV infection, strabismus, sensorineural hearing
Infectious Disorders - Drug Targets
Title: Congenital Cytomegalovirus Infection: An Overview
Volume: 11 Issue: 5
Author(s): Sean P. Elliott
Affiliation:
Keywords: Congenital cytomegalovirus, infection, neonate, sensorineural hearing loss, deafness, congenital CMV, asymptomatic, microcephaly, congenital syphilis, chorioretinitis, EPIDEMIOLOGY, hepatosplenomegaly, primary CMV infection, strabismus, sensorineural hearing
Abstract: Cytomegalovirus (CMV) remains the most common cause of congenitally-acquired infection in the United States and is a leading infectious cause of sensorineural hearing loss, cognitive delay, and permanent neurologic sequelae. Although most cases of congenital CMV infection are asymptomatic, significant morbidity and mortality exist for symptomatic infants and may also occur in asymptomatic ones. Diagnosis remains relatively straightforward, but treatment options are limited and associated with some toxicity. Efforts at prevention via vaccination, screening, and improved epidemiology deserve high priority to limit the impact of this common infection.
Export Options
About this article
Cite this article as:
P. Elliott Sean, Congenital Cytomegalovirus Infection: An Overview, Infectious Disorders - Drug Targets 2011; 11 (5) . https://dx.doi.org/10.2174/187152611797636712
DOI https://dx.doi.org/10.2174/187152611797636712 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Retraction Note: Phytochemicals from Plants to Combat Cardiovascular Disease
Current Medicinal Chemistry Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research Vascular Reactions of Iodinated X-Ray Contrast Media: Mechanisms and Possible Therapeutic Interventions
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cell and Gene Therapies in Cardiovascular Disease with Special Focus on the No Option Patient
Current Gene Therapy Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Laboratory Techniques for Human Viral Encephalitis Diagnosis
Infectious Disorders - Drug Targets Antiplatelet Therapy in the Prevention of Coronary Syndromes: Mode of Action, Benefits, Drawbacks
Cardiovascular & Hematological Agents in Medicinal Chemistry Purinergic Receptors and Pain
Current Pharmaceutical Design Arterial Stiffness As A Therapeutic Target For Isolated Systolic Hypertension: Focus on Vascular Calcification and Fibrosis
Current Hypertension Reviews The Effects of Direct Renin Inhibitor, Aliskiren, on Arterial Hypertension, Chronic Kidney Disease and Cardiovascular Disease: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Drug Therapy in Brugada Syndrome
Current Drug Targets - Cardiovascular & Hematological Disorders Genetic Signatures in the Treatment of Stroke
Current Pharmaceutical Design The First Line of Defense Against Cardiac Hypertrophy
Current Molecular Medicine Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Early Brain Injury or Vasospasm? An Overview of Common Mechanisms
Current Drug Targets Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology Pharmacological and Biological Activities of Xanthones
Anti-Infective Agents in Medicinal Chemistry Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
Infectious Disorders - Drug Targets Resident Cardiac Stem Cells
Current Pharmaceutical Design